Bringing Structure, Awareness, and Data to High-Risk Pregnancy Care

Maternal health programs around the world face a familiar challenge: screening tools can detect early risk, but the information they generate rarely connects to patient support, clinical decision-making, or population insight. This is especially critical in conditions like Preeclampsia, where early detection only makes a difference if risk is monitored, acted upon, and understood over time.
Intignus Biotech recognised this gap and envisioned a connected maternal health infrastructure - one that collects and analyses women’s health and screening data through a unified platform, designed to improve patient care, strengthen clinical decision-making, and enable public health insight.
This infrastructure unifies risk screening, ongoing patient engagement, and standardised data that can support clinicians and inform public health priorities. Their goal was not to build a standalone app, but a pathway capable of scaling across hospitals, supporting clinicians with future diagnostic tools, and strengthening population-level understanding of maternal risk.
To bring this vision to life, Intignus partnered with Avegen as a technology collaborator. Using the HealthMachine™ platform, Avegen built a secure, clinically guided digital foundation that could evolve in step with the needs of patients, clinicians, and health systems. The result is WiseMother: a digital pathway designed to support care, generate meaningful insight, and scale with the future of maternal diagnostics.
The problem
Our solution
Results
Key Takeaways
Got a condition you’re looking to treat?
Get in touch now to see how Avegen can help create a bespoke digital health solution for you.